Europe Cell Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Cell Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Cell Therapy Market Regional Analysis

6.2 Europe Cell Therapy Market Revenue 2017-2027 (US$ Million)

6.3 Europe Cell Therapy Market Forecast Analysis

7. Europe Cell Therapy Market Analysis – by Therapy Type

7.1 Allogeneic

7.1.1 Overview
7.1.2 Allogeneic: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Autologous

7.2.1 Overview
7.2.2 Autologous: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Cell Therapy Market Analysis – by Product

8.1 Consumables

8.1.1 Overview
8.1.2 Consumables: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Systems and Software

8.3.1 Overview
8.3.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Cell Therapy Market Analysis – by Technology

9.1 Viral Vector Technology

9.1.1 Overview
9.1.2 Viral Vector Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Genome Editing Technology

9.2.1 Overview
9.2.2 Genome Editing Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Somatic Cell Technology

9.3.1 Overview
9.3.2 Somatic Cell Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.4 Cell Immortalization Technology

9.4.1 Overview
9.4.2 Cell Immortalization Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.5 Cell Plasticity Technology

9.5.1 Overview
9.5.2 Cell Plasticity Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.6 Three-dimensional Technology

9.6.1 Overview
9.6.2 Three-dimensional Technology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Cell Therapy Market Analysis – by Application

10.1 Oncology

10.1.1 Overview
10.1.2 Oncology: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Cardiovascular

10.2.1 Overview
10.2.2 Cardiovascular: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.3 Orthopedic

10.3.1 Overview
10.3.2 Orthopedic: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.4 Wound Management

10.4.1 Overview
10.4.2 Wound Management: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.5 Other Applications

10.5.1 Overview
10.5.2 Other Applications: Europe Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. Europe Cell Therapy Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Cell Therapy Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 Europe Cell Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 UK: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.1.2 UK: Europe Cell Therapy Market Breakdown, by Product
11.2.1.1.3 UK: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.1.4 UK: Europe Cell Therapy Market Breakdown, by Application

11.2.1.2 Germany: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 Germany: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.2.2 Germany: Europe Cell Therapy Market Breakdown, by Product
11.2.1.2.3 Germany: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.2.4 Germany: Europe Cell Therapy Market Breakdown, by Application

11.2.1.3 France: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 France: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.3.2 France: Europe Cell Therapy Market Breakdown, by Product
11.2.1.3.3 France: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.3.4 France: Europe Cell Therapy Market Breakdown, by Application

11.2.1.4 Russia: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Russia: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.4.2 Russia: Europe Cell Therapy Market Breakdown, by Product
11.2.1.4.3 Russia: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.4.4 Russia: Europe Cell Therapy Market Breakdown, by Application

11.2.1.5 Italy: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.5.1 Italy: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.5.2 Italy: Europe Cell Therapy Market Breakdown, by Product
11.2.1.5.3 Italy: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.5.4 Italy: Europe Cell Therapy Market Breakdown, by Application

11.2.1.6 Rest of Europe: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Cell Therapy Market Breakdown, by Therapy Type
11.2.1.6.2 Rest of Europe: Europe Cell Therapy Market Breakdown, by Product
11.2.1.6.3 Rest of Europe: Europe Cell Therapy Market Breakdown, by Technology
11.2.1.6.4 Rest of Europe: Europe Cell Therapy Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Vericel Corporation

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 MEDIPOST

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 NuVasive, Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Mesoblast Limited

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Smith & Nephew

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Bristol-Myers Squibb Company

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Cells for Cells

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Stemedica Cell Technologies, Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Cell Therapy Market